Home›Search›Breast Cancer: Targets and Therapy

Breast Cancer: Targets and Therapy

Dove Medical Press Ltd · New Zealand · Est. 2009

ISSN1179-1314eISSN1179-1314

SJR Q2✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.992

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.997

Total Worksi

695

Total Citationsi

12,205

2yr Mean Citednessi

1.61

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Breast Cancer: Targets and Therapy is an international, peer reviewed, open access journal focusing on breast cancer, basic and translational research, clinical trials and treatment. The latter includes outcome studies that incorporate preventative and integrated treatment strategies for enhanced survival, and quality of life for cancer patients.

General Information

Country / RegionNew Zealand

Primary LanguageEnglish

1st Year Published2009

Annual Volume~ 86 articles / year

StatusActive (last: 2026)

Total Publications695

Publisher OrgDove Medical Press

OA Since2008

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~16 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Dove Medical Press Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1179-1314 / 1179-1314

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.3k

2019

660

2020

2021

554

2022

827

2023

235

2024

104

210

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Oncology

Research Topics (OpenAlex)

Breast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchAdvanced Breast Cancer TherapiesBreast Lesions and CarcinomasCancer Treatment and PharmacologyGlobal Cancer Incidence and ScreeningCancer Cells and MetastasisCancer Risks and FactorsEstrogen and related hormone effectsBRCA gene mutations in cancer

Frequently asked questions about Breast Cancer: Targets and Therapy

Is Breast Cancer: Targets and Therapy a predatory journal?

PubScope has no integrity flags on record for Breast Cancer: Targets and Therapy: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Breast Cancer: Targets and Therapy?

Breast Cancer: Targets and Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.61.

Is Breast Cancer: Targets and Therapy indexed in Scopus and Web of Science?

Breast Cancer: Targets and Therapy is indexed in Web of Science, Scopus, DOAJ.